Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood by Honkamäki, Jasmin et al.
Contents lists available at ScienceDirect
Respiratory Medicine
journal homepage: www.elsevier.com/locate/rmed
Age- and gender-specific incidence of new asthma diagnosis from childhood
to late adulthood
Jasmin Honkamäkia, Hanna Hisinger-Mölkänenb, Pinja Ilmarinenc, Päivi Piiriläd,
Leena E. Tuomistoc, Heidi Anderséne, Heini Huhtalaf, Anssi Sovijärvid, Helena Backmang,
Bo Lundbäckh, Eva Rönmarkg, Lauri Lehtimäkia,i, Hannu Kankaanrantaa,c,*
a Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
bHeart and Lung Center, Helsinki University Hospital, Helsinki, Finland
c Department of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland
dUnit of Clinical Physiology, HUS Medical Imaging Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
e Department of Respiratory Medicine, Vaasa Central Hospital, Vaasa, Finland
f Faculty of Social Sciences, Tampere University, Tampere, Finland
g Department of Public Health and Clinical Medicine, Division of Occupational and Environmental Medicine/the OLIN Unit, Umeå University, Umeå, Sweden
h Krefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
iAllergy Centre, Tampere University Hospital, Tampere, Finland
A R T I C L E I N F O
Keywords:
Asthma
Incidence
Prevalence
Gender
Adult
Phenotype
A B S T R A C T
Background: Asthma is currently divided into different phenotypes, with age at onset as a relevant differentiating
factor. In addition, asthma with onset in adulthood seems to have a poorer prognosis, but studies investigating
age-specific incidence of asthma with a wide age span are scarce.
Objective: To evaluate incidence of asthma diagnosis at different ages and differences between child- and adult-
diagnosed asthma in a large population-based study, with gender-specific analyzes included.
Methods: In 2016, a respiratory questionnaire was sent to 8000 randomly selected subjects aged 20–69 years in
western Finland. After two reminders, 4173 (52.3%) subjects responded. Incidence rate of asthma was retro-
spectively estimated based on the reported age of asthma onset. Adult-diagnosed asthma was defined as a
physician-diagnosis of asthma made at ≥ 18 years of age.
Results: Among those with physician-diagnosed asthma, altogether, 63.7% of subjects, 58.4% of men and 67.8%
of women, reported adult-diagnosed asthma. Incidence of asthma diagnosis was calculated in 10-year age groups
and it peaked in young boys (0–9 years) and middle-aged women (40–49 years) and the average incidence rate
during the examined period between 1946 and 2015 was 2.2/1000/year. Adult-diagnosed asthma became the
dominant phenotype among those with physician-diagnosed asthma by age of 50 years and 38 years in men and
women, respectively.
Conclusions: Asthma is mainly diagnosed during adulthood and the incidence of asthma diagnosis peaks in
middle-aged women. Asthma diagnosed in adulthood should be considered more in clinical practice and man-
agement guidelines.
1. Introduction
The recent re-identification of phenotypes has increased awareness
of asthma as a heterogeneous disease [1,2]. Phenotypes are dis-
tinguished by age of asthma onset [1,2], and asthma with onset later in
life seems to have a poorer prognosis [1,3,4]. Epidemiological factors
associated with asthma and wheezing at an early age are well estab-
lished [5,6]. However, less is known about incidence as the examined
age span is widened to late adulthood.
A substantial incidence of wheezing in childhood with a high re-
mission rate is described by several cohort studies [6–8]. For instance,
in the Tucson cohort 50% of subjects had experienced at least one
episode of wheezing during preschool age and 9.6% had been diag-
nosed with asthma at 6 years of age [9], which stands for an average
incidence of physician-diagnosed asthma of 16/1000/year during pre-
school age. Atopy and male gender are commonly reported risk factors
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for wheezing in childhood [7,9–11]. After preschool age, the incidence
declines [7,11,12], especially in boys [13,14].
The few longitudinal studies about adult-onset asthma have mostly
reported the incidence to be 1.4–5/1000/year and higher in women
[15–20]. Studies have varying age spans and the incidence in older
subjects is less studied, although increasing incidence with age after
mid-adulthood has been described [14,15,17]. Further, recent results
from the US suggest that adult-onset asthma becomes the dominant
phenotype in women quite early, at age 40 years [21], and novel data
based on the entire population of Finland show similar results [13].
Nevertheless, further evidence is needed for verification of age-specific
asthma incidence especially in subjects over 40 years of age. Therefore,
the aim of this study was to evaluate gender-specific incidence of
asthma diagnosis at different ages in a large population-based random
sample of adults.
2. Methods
2.1. Data acquisition
As a part of the FinEsS (Finland-Estonia-Sweden) -study, a re-
spiratory questionnaire was sent to a random sample of 8000 subjects
aged 20–69 years in western Finland (the hospital district areas of
South Ostrobothnia and Vaasa, with about 200 000 and 170 000 in-
habitants in 2016, respectively) in February 2016. The study area is
mainly rural containing two major towns, Seinäjoki and Vaasa. Both
elderly and bilinguals (Finnish and Swedish) are numerous in the po-
pulation. Subjects and their personal details were identified from the
Finnish Population Register, and the sample reflected age and sex dis-
tribution of the population in the study area. Up to three postal rounds
were carried out or until a response was got. The registered native
language of each subject determined whether questionnaire in Finnish
or Swedish was applied. Subjects with other native languages were sent
a Finnish questionnaire on the two first rounds and a Swedish ques-
tionnaire on the third round.
The current study was approved by the ethics committee of Helsinki
University Hospital. Concurrently with this study a similar FinEsS-study
was conducted in Helsinki with identical questionnaire and corre-
sponding protocols.
2.2. Questionnaire
The FinEsS questionnaire (FQ) is developed from the Obstructive
Lung Disease in Northern Sweden (OLIN) questionnaire, which is
modified from the Swedish version of the British Medical Research
Council (BMRC) questionnaire [22]. FQ comprises questions on re-
spiratory symptoms and diseases, their comorbidities and suggested risk
factors, use of medication and occupation, and it has been previously
used in several Nordic and Estonian studies [17,23,24].
2.3. Definition of key parameters
Physician-diagnosed allergy was defined by a positive response to
“Have you been diagnosed by a doctor as having allergic rhinitis caused
by pollen (caused by e.g. birch, grass, mugwort)?” or “Have you been
diagnosed by a doctor as having other allergic rhinitis (caused by e.g.
cat or dog, but not caused by pollen)?” A positive response to “Have you
been diagnosed by a doctor as having asthma?” was considered as a
definition of physician-diagnosed asthma, and age at asthma diagnosis
was assessed with question “What age were you when asthma was di-
agnosed?” Asthma diagnosed at≥ 18 years of age was defined as adult-
diagnosed asthma, and< 18 years of age as child-diagnosed asthma. A
sensitivity analysis was conducted with adult-diagnosed asthma defined
as asthma diagnosed at ≥ 15 years of age. Prevalence of asthma was
defined as the proportion of responders reporting physician-diagnosed
asthma.
Incidence of asthma diagnosis was assessed in 10-year age groups in
cross-sectional data, as previously described [25]. Briefly, subjects were
separated into 10-year age groups based on their current age, and “new
asthma diagnoses/1000/year” was calculated by dividing the number
of incident asthma diagnoses in each group by age-group-specific po-
pulation at risk, dividing the result by 10 and finally multiplying with
1000.
Each 10-year age group -specific population at risk was a mean
value of annually calculated respective 10-year risks. With respect to
age 0, all responders were at risk. For ages 1–20 years, subjects re-
porting asthma diagnosed at younger age than the age in question were
annually subtracted from the original population at risk (i.e. all re-
sponders) to form 1-year populations at risk. 20 years was the age of the
youngest responders. Therefore, asthma-naïve responders younger than
the age for which the population at risk was calculated were further
subtracted from all responders to assess populations at risk for ages
21–69. This subtraction procedure was applied, since responders could
not have reported asthma diagnosis at older age than themselves at the
time of response. Asthma-naïve responders were responders not re-
porting physician-diagnosed asthma. Assessing overall incidence, de-
nominator for all diagnosed asthma cases was an average of annual
populations at risk, and the result was further divided by 70, which was
the length of the examined period in years. Subjects reporting physi-
cian-diagnosed asthma but not the age at diagnosis were excluded from
incidence calculations.
Subjects with incomplete smoking data were included in non-re-
sponder analyses but excluded from all the other analyses to allow
comparison of the results with Helsinki FinEsS-data.
2.4. Statistical analyses
Statistical analyses were performed using SPSS statistics version 23
and 95% confidence intervals (CI) were calculated with EpiTools
(http://epitools.ausvet.com.au) using the Wilson method, which allows
CI calculation for relative proportions [26]. Percentage ranges in par-
entheses reflect CI. The distributions of continuous variables were
evaluated, and when normally distributed, shown were mean (SD) and
when non-normally distributed, shown were median (IQR). A Mann-
Whitney U -test was used for continuous and chi-square -test for cate-
gorical variables to test between groups, and a p-value of< 0.05 was
considered significant.
3. Results
3.1. Characteristics of responders and prevalence of asthma
Of the 8000 invited subjects, 4173 (52.3%) responded (Fig. 1).
Median age of the responders was 53 years (Table 1). The responders
were more often women (52.6% vs. 44.5%) and older (median age 53
vs. 40 years) compared to the non-responders.
After exclusion of subjects with incomplete smoking data (n= 206),
445 of 3967 subjects (11.2%, 10.3–12.2%) reported physician-diag-
nosed asthma. Further, physician-diagnosed asthma was reported by
192 of 1898 men (10.1%, 8.8–11.6%) and 253 of 2069 women (12.2%,
10.9–13.7%). 706 subjects reported physician-diagnosed allergy which
resulted in prevalence of 17.8% (16.6–19.0%). Of subjects reporting
physician-diagnosed asthma 88 (19.8%) were current smokers and 149
(33.5%) ex-smokers. Further, incident asthma was significantly asso-
ciated with BMI in all subjects and women (Table 2 and Table 3).
Smoking and BMI data in subjects categorized by age under or over 50
years is reported in detail in the Online Repository.
3.2. Age at diagnosis of asthma
In total, 427 subjects reporting physician-diagnosed asthma, 185
men and 242 women, reported also the age at asthma diagnosis. Median
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age at diagnosis was 21 (IQR 7–43) years in men and 29 (IQR 15–44)
years in women (p=0.026). Altogether, 36.3% of subjects with phy-
sician-diagnosed asthma (31.9–41.0%) reported asthma diagnosis in
childhood (< 18 years) and 63.7% (59.0–68.1%) in adulthood (≥18
years) (Fig. 2). Men were diagnosed with asthma more often during
childhood than women: 41.6% (34.8–48.8%) versus 32.2%
(26.7–38.4%), respectively (p=0.046). Accordingly, the proportions
of adult-diagnosed asthma were 58.4% (51.2–65.2%) in men, and
67.8% (61.6–73.3%) in women. A sensitivity analysis using a cut-point
at 15 years also indicated prominence of adult-diagnosed asthma (see
this article's Online Repository).
After excluding subjects who reported physician-diagnosed asthma
but not the age at diagnosis (n= 18), incidence was calculated in 10-
year age groups (Fig. 3). In men, incidence peaked in childhood and
was followed by a low and flat rate in adolescence and early adulthood
with a slight upward trend towards late adulthood. In women, a stable
trend was interrupted by a high peak in mid-adulthood (40–49 years)
following a descending trend towards the oldest age group (60–69
years). On average, the incidence rate was 2.2/1000/year. Gender-
specific incidence of child- and adult-diagnosed asthma are presented in
Table 4. An analysis of decennial incidence of new asthma diagnosis
showed increasing incidence during the whole inspected period from
1946 to 2015 (see this article's Online Repository).
The number of adult-diagnosed asthma exceeded the number of
child-diagnosed asthma i.e. became the dominant phenotype in women
by age of 38 years and in men by age of 50 years (Fig. 4).
3.3. Validation of the main result
Data from Helsinki, collected with equal methods concurrently with
the current study, was compared to our data from western Finland. In
western Finland the proportions of child-diagnosed and adult-diag-
nosed asthma were 36.3% and 63.7%, respectively, as described above,
and the corresponding proportions in Helsinki were 45.1%
(40.2–50.0%) and 54.9% (50.0–59.8%), respectively.
4. Discussion
In this random population sample of adults, asthma diagnosis at
adult age was more common than diagnosis in childhood. The incidence
peaked in young boys (0–9 years) and middle-aged women (40–49
years). Finally, adult-diagnosed asthma became the dominant pheno-
type by age of 50 and 38 years in men and women, respectively.
Prevalence of physician-diagnosed asthma was 11.2% and is similar
with novel reports from Nordic studies [27,28]. Prevalence was higher
in boys than girls but higher in women than men and the gender re-
versal occurred in adolescence, as previously described [10,13]. The
prevalence of physician-diagnosed allergy was 17.8%, and a recent
Finnish study estimated it somewhat higher, but it assessed self-re-
ported allergy [27]. Allergy prevalence varies notably between studies
depending on the area and definition [29].
Incidence of asthma diagnosis in 0-18-year-old children was 2.2/
1000/year, being low compared to prospective studies [6–8] which
generally produce higher incidence estimates [7,12]. Reporting asthma
onset is found to be less sensitive retrospectively [30,31], implying that
Fig. 1. Flow chart of the study.
Table 1
Basic characteristics of responders.
All, N= 4173 Men, N=1976 Women, N=2197
Age (yrs), median
(IQR)
53 (38–63) 54 (39–63) 53 (38–63)
BMI (kg/m2), mean
(SD)
26.7 (4.9) 27.2 (4.4) 26.3 (5.2)
Native language, n (%)
Finnish 2932 70.3 1368 69.2 1564 71.2
Swedish 1132 27.1 554 28.0 578 26.3
Other 109 2.6 54 2.7 55 2.5
Physician-diagnosed
allergy, n (%)
745 17.9 316 16.0 429 19.5
Smoking, n (%)
Current 798 20.1 471 24.8 327 15.8
Ex 1086 27.4 635 33.5 451 21.8
Never 2083 52.5 792 41.7 1291 62.4
Family history of
asthma, n (%)
1058 25.4 406 20.5 652 29.7
Physician-diagnosed
chronic
bronchitis or
COPD, n (%)
107 2.6 59 3.0 48 2.2
Living in rural area
<5 years of
age, n (%)
2859 70.1 1371 71.1 1488 69.2
BMI is based on responses of 4070 in all, 1932 in male and 2138 in female,
smoking of 3967 in all, 1898 in male and 2069 in female, and rural childhood of
4080 in all, 1929 in male and 2151 in female subjects. IQR= interquartile
range, SD= standard deviation.
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milder asthma is left out. In addition, child-onset asthma is particularly
sensitive to recall bias since in three out of four school-aged children
asthma remits by mid-adulthood [6,32]. Thus, the incidence may be
higher than reported here. However, our subjects reported age at
asthma diagnosis which is invariably based on objective lung function
testing in Finland, as the national guidelines require [13,33]. Therefore,
the share of false positives is lower. In conclusion, we consider that
child-diagnosed cases are reliable but represent more persistent and
severe asthma, which corresponds to adult-diagnosed asthma that is
less often mild [1–4].
Overall adult-diagnosed asthma incidence was 2.2/1000/year, well
in line with three large adult incidence studies from Sweden performed
1985–2006 each with about 10-year follow-up [16,19,20], and also
with most other adult-onset asthma studies [15,18]. Asthma diagnosis
is associated with special asthma medication reimbursement and state-
funded financial benefits in Finland [13], resulting better recall of
asthma diagnosis in adults. Furthermore, self-reported asthma onset
reportedly has a very good specificity [30,31]. In conclusion, we con-
sider adult-diagnosed asthma cases reliable and the number of reported
diagnoses comprehensive.
Overall incidence during 1946–2015 was 2.2/1000/year in parallel
to one study that reached> 50-year-old subjects [13], and another
with a narrower age span but similar setting as the current study [14].
Further, age-specific incidence was higher in boys (0–9 years), equal in
both genders during adolescence (10–19 years), and after that higher in
women, also in parallel with earlier findings [10,12,13,25]. Boys are
more prone to develop asthma in childhood [7,9], but persistence is
associated with female gender [6,8], and sex hormones may cause
susceptibility to different environmental factors [10,34]. The age- and
gender-centered risk assessment seems to differentiate the patients well,
and utilizing a simple characterization new asthma is easier to identify.
This may result in less overlook and shorter delay of asthma diagnosis.
Therefore, complications will be avoided and the quality of life in pa-
tients enhanced. As asthma is common in the population and over
200 000 people possessed right to asthma reimbursement in Finland in
201313, financial burden would consequently be significantly lessened.
Age-specific incidence rose towards late adulthood, as described
earlier, but controversial results do also exist [15,18,20]. Incidence was
particularly high in middle-aged women, and quite similar findings are
reported [20,25]. It may be reflecting hormonal changes in mid-
Table 2
Prevalence of physician-diagnosed asthma in different subgroups and comparison of responders with and without physician-diagnosed asthma.
Prevalence of asthma in given
subgroups (%),N=3967
Responders with physician-diagnosed
asthma, N=445
Responders without physician-diagnosed
asthma, N=3522
P-value
Age (yrs), median (IQR) N/D 51 (35–63) 53 (38–63) 0.113
Gender, n (%) 0.035
Male 10.1 192 43.1 1706 48.4
Female 12.2 253 56.9 1816 51.6
BMI (kg/m2), mean (SD) N/D 27.4 (5.5) 26.6 (4.8) 0.020
Smoking, n (%) 0.007
Current 11.0 88 19.8 710 20.2
Ex 13.7 149 33.5 937 26.6
Never 10.0 208 46.7 1875 53.2
Family history of asthma, n (%) < 0.001
Yes 20.6 208 46.7 802 22.8
No 8.0 237 53.3 2720 77.2
Physician-diagnosed chronic
bronchitis or COPD, n (%)
< 0.001
Yes 43.4 43 9.7 56 1.6
No 10.4 402 90.3 3466 98.4
BMI is based on responses of 3886 subjects. Gender-specific values have been calculated on the total of male and female subjects. IQR= interquartile range,
SD= standard deviation.
Table 3
Gender-specific comparison of subjects in relation to physician-diagnosed asthma.
Men, N=1898
Physician-diagnosed asthma
P-value Women, N=2069
Physician-diagnosed asthma
P-value
Yes N=192 No N=1706 Yes N=253 No N=1816
Age (yrs), median (IQR) 50 (34–63) 54 (40–63) 0.023 52 (35–64) 52 (38–62) 0.972
BMI (kg/m2), mean (SD) 27.9 (5.3) 27.1 (4.3) 0.333 27.1 (5.7) 26.2 (5.1) 0.018
Smoking, n (%) 0.156 0.007
Current 45 23.4 426 25.0 43 17.0 284 15.6
Ex 76 39.6 559 32.8 73 28.9 378 20.8
Never 71 37.0 721 42.3 137 54.2 1154 63.5
Family history of asthma, n (%) < 0.001 <0.001
78 40.6 312 18.3 130 51.4 490 27.0
Physician-diagnosed chronic bronchitis or COPD n (%) < 0.001 <0.001
24 12.5 30 1.8 19 7.5 26 1.4
BMI is based on responses of 1864 subjects in men and 2022 in women. IQR= interquartile range, SD= standard deviation.
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adulthood, such as menopause, which is recently identified as a strong
predictor of asthma in women not using exogenous hormones [35]. In
addition, one often reported adult-onset asthma phenotype is obesity-
related, consisting more female subjects with later onset asthma (> 40
years) [2,36]. Interestingly, BMI was also associated with the incidence
of asthma in this study, in line with other Scandinavian studies [37].
Nevertheless, this phenomenon in women is significant and should be
further investigated.
Proportion of adult-diagnosed asthma was higher than child-diag-
nosed, confirmed with the data from Helsinki. The result is in line with
another study [13], which examined the whole age span and had an
equivalent cut-point to our study (at 18 years). Since we had different
aged responders and did not include subjects ≥70 years of age, al-
though asthma can be found at any age [38], adult-diagnosed group
lacked person-years and therefore underestimated the number of adult
diagnoses. Nevertheless, our data probably underestimate the
proportion of child-onset asthma and distinction between the two
phenotypes might be overestimated. However, similar data for 70 years
would be difficult to collect prospectively, and our data clearly de-
scribes adult-onset asthma as a notable phenomenon.
Understanding different asthma etiologies and their relative prob-
abilities regarding age at onset in adult patients is important for phy-
sicians especially if the era of asthma phenotyping proceeds to clinical
work. In our study, adult-onset asthma became the dominant phenotype
in women by age 38 years, in line with two earlier reports [13,21]. A
study from the US defined adult-onset asthma onset at ≥ 18 years of
age, similarly to our study, whereas a Finnish study used a cut-point at
15 years [13,21]. The US study reported that child-onset asthma was
still the dominant phenotype in 50-year-old men, differing from our
result [21]. Averagely shorter recall periods and prospective design,
leading to inclusion of mild asthma in the US study may explain the
slightly different result. However, our result regarding men is in line
with those of the previous Finnish study [13], which only included
patients who had been granted with a special medication reimburse-
ment, indicating that all patients had objectively diagnosed, more
persistent asthma.
Smoking has been associated with asthma in incidence studies [20],
while most cross-sectional studies have found association with ex-
smoking [28,39], similarly to this study. This is presumably explained
by the “healthy smoker effect”: bias caused by smoking cessation be-
cause of excessive respiratory symptoms and asthma diagnosis [16]. In
addition, asthma-COPD overlap (ACO) is recently identified [40]. Pa-
tients with asthma smoke as often as non-asthmatics and in adult
asthma populations many have at least some smoking history
[3,28,36,38]. In previous adult asthma studies the exclusion of current
smokers or patients with smoking history might lower the incidence
estimates in adults, and the influence is emphasized in women, in
whom smoking is a higher risk factor for asthma onset [39]. In Finland
COPD is diagnosed with objective lung function tests which serve as a
basis for medication reimbursement, similarly as in asthma [13,33].
Nevertheless, we cannot exclude some misclassification between
asthma and COPD, especially in elderly patients, since COPD usually
occurs after 50 years of age. However, the majority of patients with
asthma diagnosed>40 years of age were women, in which significant
smoking history is less common in Finland [41]. Thus, we consider that
the bias due to misclassification of COPD as asthma does not explain the
higher numbers of newly-diagnosed asthma in older women.
In the last three decades, over 130 birth cohorts on asthma and
allergies have been initiated [5]. In contrast, similar adult cohort stu-
dies are scarce. Although some birth cohorts suggest that adult-onset
asthma may have manifested in childhood [5,7], adult- and child-onset
Fig. 2. Gender-specific proportions of asthma diagnosed during childhood and
adulthood with 95% CI:s.
Fig. 3. Age- and gender-specific incidence rates of new asthma diagnosis with
95% CI:s.
Table 4
Gender-specific incidence rates of child- and adult-diagnosed asthma.
Incidence/1000/year All Men Women
Overall 2.2 2.0 2.4
Child-diagnosed (< 18) 2.2 2.3 2.1
Adult-diagnosed (≥18) 2.2 1.8 2.6
Fig. 4. The ratio of adult-diagnosed asthma in relation to child-diagnosed
asthma in males and females. At the age point that the curve crosses level 1,
adult-diagnosed asthma becomes the dominant phenotype.
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asthma have highly distinct characteristics and treatment response,
implying that it may be appropriate to study them as separate entities
[1,2,42]. In addition, adult-onset asthma is more often associated with
environmental risk factors, implying that substantial potential for pre-
vention exists [42]. In a clinical study with population from the same
area as in the current study, 24% of adult patients with verified new-
onset asthma had had asthma symptoms in childhood [36] and a case-
control study from Sweden found that approximately 10% of subjects
with recently diagnosed asthma had been symptomatic before [37].
Therefore, it is justified to assume that most of adult-diagnosed asthma
in the current study is also adult-onset asthma. Further, making asthma
diagnosis in young children is complex due to lack of appropriate lung
function tests and although the incidence of wheezing is substantial, it
should not be too eagerly classified as asthma [43]. Furthermore, not
every early wheezer develops asthma in adulthood, and neither does
every adult-diagnosed asthma patient have wheezing history [7]. Small
airway caliber and viral infections can also act as confounders [9]. In
conclusion, we believe that adult-onset asthma is a separate entity with
unidentified potential for prevention. It should not usually be con-
sidered as a reactivation of child-onset asthma, or having similar
characteristics.
The response rate in the present study was 52.3%, being moderate,
considering that response rates in respiratory epidemiology have de-
clined during the last decades [44,45]. Studies investigating non-re-
sponse bias have found non- and late responders to differ from initial
responders by being more often males, younger people and current
smokers, correspondingly with the data available in this study
[16,44,45]. In addition, these studies report varying results on differ-
ences between proportion of asthmatics in responders versus non- and
late responders. However, none of these studies stated that using re-
minders or nonresponse bias significantly affected the prevalence or
odds ratios related to asthma, even if the response rate was< 50%. A
telephone interview non-responder study was planned as a part of the
current study, but ethical permission was not granted. Nevertheless, we
conclude that this study might have included some non-responder bias,
which mainly affects younger and males.
The main weaknesses of the current study are as follows. Firstly,
recall bias is present due to the long recall periods in some asthma
cases. Secondly, our responders were more often older and women and
therefore results are susceptible to nonresponse bias. Thirdly, the
highest age groups (≥ 70 years) are missing. Finally, due to the in-
clusion of subjects with significant smoking history, we have probably
interpreted some COPD as asthma in older subjects. However, the
present study also has many strengths. We had a large sample reflecting
general population and a relatively good response rate, and used a
questionnaire with well proven validity. Subjects were asked about
physician-diagnosed asthma which is diagnosed with objective methods
and associated to financial benefits in Finland, diminishing recall bias
and securing better validity of asthma cases. Lastly, we had a very wide
age span which would be extremely difficult to achieve without major
drop out prospectively.
In conclusion, adult-onset asthma is a common phenotype and a
major burden to the healthcare system. The incidence of adult-onset
asthma peaks in middle-aged women. By investigating the poorly un-
derstood etiology of new asthma in adult subjects, new approaches to
pathogenesis, preventive strategies and effective treatment methods
could be discovered. This would lead to upgraded guidelines and major
economical and public health improvements.
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